Monica L. Guzman, Craig T. Jordan  Cancer Cell 

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Age-associated changes in human hematopoietic stem cells
by Jad I. Belle, David Langlais, Jessica C
T-ALL: Home Is where the CXCL12 Is
Maintenance of the Hematopoietic Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell Niches  Tatsuki Sugiyama, Hiroshi Kohara,
Myeloid Cells Stimulate Their Progenitors in an Emergency
Martin Wahlestedt, David Bryder  Cell Stem Cell 
9-1-1: HSCs Respond to Emergency Calls
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Luis A. Carvajal, Ulrich Steidl  Cell Stem Cell 
Accelerating drug discovery: Open source cancer cell biology?
Christopher Hine, James R. Mitchell  Cell Stem Cell 
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Blocking HIF1α Activity Eliminates Hematological Cancer Stem Cells
Andrew G. Muntean, Jay L. Hess  Cancer Cell 
CALming Down T Cell Acute Leukemia
Christopher Hine, James R. Mitchell  Cell Stem Cell 
MDS Is a Stem Cell Disorder After All
Alyson A. Lokken, Nancy J. Zeleznik-Le  Cancer Cell 
Stressed-Out HSCs Turn Up p38α and Purine to Proliferate
Volume 21, Issue 20, Pages R837-R838 (October 2011)
A New Image of the Hematopoietic Stem Cell Vascular Niche
Daichi Inoue, Omar Abdel-Wahab  Cancer Cell 
Volume 2, Issue 4, Pages (April 2008)
CALming Down T Cell Acute Leukemia
Immune-Cell Lineage Commitment: Translation from Mice to Humans
Combinatorial Haplo-Deficient Tumor Suppression in 7q-Deficient Myelodysplastic Syndrome and Acute Myeloid Leukemia  Britta Will, Ulrich Steidl  Cancer.
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
María García-Fernández, Simón Méndez-Ferrer  Cell Stem Cell 
Blocking HIF1α Activity Eliminates Hematological Cancer Stem Cells
Volume 20, Issue 2, Pages (August 2011)
Erin J. Oakley, Gary Van Zant  Cell Stem Cell 
Intimacy of the Niche: Perivascular Remodeling Cuddles Incoming HSCs
HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo
Volume 22, Issue 4, Pages e4 (April 2018)
Volume 2, Issue 4, Pages (April 2008)
Meddling with METTLs in Normal and Leukemia Stem Cells
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
On the Origin of Leukemic Species
Volume 15, Issue 4, Pages (April 2009)
Volume 121, Issue 7, Pages (July 2005)
Volume 11, Issue 3, Pages (September 2012)
aSIRTing Control over Cancer Stem Cells
Hematopoietic Stem Cells in Transit— Where's the Niche?
What is quality in a transplant program?
Disrupting the Stem Cell Niche: Good Seeds in Bad Soil
Volume 8, Issue 1, Pages (January 2011)
Keeping Off the Weight with DCs
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
The Hidden Memory of Differentiating Cells
Tailor Made Protein Synthesis for HSCs
It’s ALL in the Family: IKZF1 and Hereditary Leukemia
Simón Méndez-Ferrer, María García-Fernández, Carlos L.F. de Castillejo 
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Attacking Cancer at Its Root
Mary Eapen  Biology of Blood and Marrow Transplantation 
Searching for leukemia stem cells—Not yet the end of the road?
There's a Time and a Place for MYCN
Volume 13, Issue 4, Pages (April 2008)
Cellular Alchemy and the Golden Age of Reprogramming
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
The Role of TET2 in Hematologic Neoplasms
Presentation transcript:

Lessons Learned from the Study of JunB: New Insights for Normal and Leukemia Stem Cell Biology  Monica L. Guzman, Craig T. Jordan  Cancer Cell  Volume 15, Issue 4, Pages 252-254 (April 2009) DOI: 10.1016/j.ccr.2009.03.008 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Competitive Repopulation Assays and Hematopoietic Stem Cell Frequency Studies in normal hematopoietic cells (top) are typically performed with either unfractionated bone marrow (BM) or enriched stem cell populations (blue panel at right). In perturbed genetic systems, such as junB-deficient mice (bottom), higher proliferation and/or skewed differentiation cause an increased pool of myeloid progenitors. The accumulation of such cells can lead to erroneous conclusions when nonpurified populations are used for the assay (blue panel at right). Using the same assays with highly purified LT-HSC populations (green panel at left), Santaguida et al. (2009) revealed that there are no functional differences in the LT-HSCs of junB-deficient mice in comparison to wild-type controls. HSPC, hematopoietic stem and progenitor cell; MPD, myeloproliferative disease. Cancer Cell 2009 15, 252-254DOI: (10.1016/j.ccr.2009.03.008) Copyright © 2009 Elsevier Inc. Terms and Conditions